Contract 36E79723D0029
Radha Pharmaceuticals Inc · Department Of Veterans Affairs · September 29, 2023
Radha Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 29, 2025. If all options are exercised, the contract could reach $23.50 million.
Contract details
- PIID
- 36E79723D0029
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 29, 2023
- Latest action
- October 29, 2025
Description
EXERCISE OPTION YEAR 2 FOR GABAPENTIN TABLETS. PERIOD OF PERFORMANCE IS 1/1/2026 - 12/31/2026. PRICES REMAIN UNCHANGED.
Modification timeline
-
October 29, 2025Mod P00003 · Exercise An Option$0
-
October 29, 2024Mod P00002$0
-
September 29, 2023Base awardAWARD TO RADHA PHARMACEUTICALS INC FOR GABAPENTIN TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79723D0029?
Contract 36E79723D0029 is a federal contract awarded to Radha Pharmaceuticals Inc by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79723D0029?
Radha Pharmaceuticals Inc won contract 36E79723D0029 from Department Of Veterans Affairs.
How much is contract 36E79723D0029 worth?
Contract 36E79723D0029 has obligated $0 to date but carries a potential ceiling of $23.50 million if fully funded and all options are exercised.